Novadip Biosciences
Tissue regenerative medicine for severe bone defects
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Novadip Biosciences is a Belgian biotech developing regenerative therapies to repair severe bone defects. Its lead program NVD003 is an autologous cell-based therapy for congenital pseudarthrosis of the tibia and is in a pivotal Phase 3 study in the United States and Europe.
- Website
- novadip.com
- Location
- Louvain-la-Neuve, Belgium
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Novadip NVD003 — Autologous cell therapy for congenital pseudarthrosis of the tibia · Other